WallStSmart

Cintas Corporation (CTAS)vsMaximus Inc (MMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cintas Corporation generates 101% more annual revenue ($10.79B vs $5.37B). CTAS leads profitability with a 17.6% profit margin vs 6.9%. MMS appears more attractively valued with a PEG of 2.06. MMS earns a higher WallStSmart Score of 64/100 (C+).

CTAS

Buy

60

out of 100

Grade: C+

Growth: 6.0Profit: 9.0Value: 4.7Quality: 7.3
Piotroski: 6/9Altman Z: 4.29

MMS

Buy

64

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 10.0Quality: 8.5
Piotroski: 6/9Altman Z: 2.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTASSignificantly Overvalued (-78.1%)

Margin of Safety

-78.1%

Fair Value

$112.48

Current Price

$176.85

$64.37 premium

UndervaluedFair: $112.48Overvalued
MMSUndervalued (+75.2%)

Margin of Safety

+75.2%

Fair Value

$305.14

Current Price

$67.81

$237.33 discount

UndervaluedFair: $305.14Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTAS4 strengths · Avg: 9.3/10
Return on EquityProfitability
43.4%10/10

Every $100 of equity generates 43 in profit

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

Market CapQuality
$70.75B9/10

Large-cap with strong market position

Operating MarginProfitability
23.4%8/10

Strong operational efficiency at 23.4%

MMS4 strengths · Avg: 9.3/10
P/E RatioValuation
10.4x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
146.5%10/10

Earnings expanding 146.5% YoY

Return on EquityProfitability
22.1%9/10

Every $100 of equity generates 22 in profit

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

CTAS3 concerns · Avg: 3.3/10
P/E RatioValuation
38.4x4/10

Premium valuation, high expectations priced in

Price/BookValuation
15.2x4/10

Trading at 15.2x book value

PEG RatioValuation
2.922/10

Expensive relative to growth rate

MMS4 concerns · Avg: 3.0/10
PEG RatioValuation
2.064/10

Expensive relative to growth rate

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Debt/EquityHealth
1.013/10

Elevated debt levels

Revenue GrowthGrowth
-4.1%2/10

Revenue declined 4.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CTAS

The strongest argument for CTAS centers on Return on Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 17.6% and operating margin at 23.4%.

Bull Case : MMS

The strongest argument for MMS centers on P/E Ratio, EPS Growth, Return on Equity.

Bear Case : CTAS

The primary concerns for CTAS are P/E Ratio, Price/Book, PEG Ratio.

Bear Case : MMS

The primary concerns for MMS are PEG Ratio, Profit Margin, Debt/Equity.

Key Dynamics to Monitor

CTAS profiles as a mature stock while MMS is a value play — different risk/reward profiles.

CTAS carries more volatility with a beta of 0.94 — expect wider price swings.

CTAS is growing revenue faster at 9.3% — sustainability is the question.

CTAS generates stronger free cash flow (425M), providing more financial flexibility.

Bottom Line

MMS scores higher overall (64/100 vs 60/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cintas Corporation

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Cintas Corporation is an American corporation headquartered in Cincinnati, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses.

Maximus Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Maximus, Inc. provides Business Process Services (BPS) to government health and human services programs worldwide. The company is headquartered in Reston, Virginia.

Visit Website →

Want to dig deeper into these stocks?